Standout Papers

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Comm... 2021 2026 2022 2024357
  1. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 (2021)
    Julia W. Gargano, Megan Wallace et al. MMWR Morbidity and Mortality Weekly Report
  2. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 (2021)
    Jessica R. MacNeil, John R. Su et al. MMWR Morbidity and Mortality Weekly Report

Immediate Impact

5 by Nobel laureates 1 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

The therapeutic potential of circular RNAs
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
2 intermediate papers

Works of Veronica V. McNally being referenced

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
2021 Standout

Author Peers

Author Last Decade Papers Cites
Veronica V. McNally 189 125 422 191 11 703
Hannah G. Rosenblum 190 170 417 59 16 729
Jane Baumblatt 87 160 243 56 15 725
A. R. Hinman 232 446 392 203 28 821
Mohammad Hossein Razizadeh 140 105 329 33 34 653
Nan-Chang Chiu 61 248 304 60 22 702
Daina B. Esposito 185 311 218 66 36 724
Alasdair Munro 137 109 416 20 29 726
Jay R Montgomery 34 84 304 249 12 589
Reut Ohana 134 80 455 187 4 657
David Leeman 40 43 512 51 15 677

All Works

Loading papers...

Rankless by CCL
2026